home / stock / cybn:cc / cybn:cc news


CYBN:CC News and Press, CYBIN INC. From 04/22/22

Stock Information

Company Name: CYBIN INC.
Stock Symbol: CYBN:CC
Market: AQNC

Menu

CYBN:CC CYBN:CC Quote CYBN:CC Short CYBN:CC News CYBN:CC Articles CYBN:CC Message Board
Get CYBN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

CYBN:CC - Cybin to Participate in the KCSA Psychedelics Virtual Investor Conference on April 28, 2022

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) (“ Cybin ” or the “ Company ”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™” is pleased to announce that Doug Drysdale, Cybin’s Chie...

CYBN:CC - Volume of Gray Matter May Be Useful in Treatment Planning for Mental Health Conditions

New research has found that examining the brain structure of patients with recent onset of depression and psychosis may help identify those who are more likely to have poor outcomes. The researchers believe that physicians will be able to offer these patients more effective, targeted treat...

CYBN:CC - Roth Capital Reveals Top Psychedelic Picks in New Industry Report

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Investment banks are continuing to release positive coverage for psychedelic stocks and the latest report from Roth Capital is no exception. On April 19, Roth Capita...

CYBN:CC - Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) ( Cybin or the Company ), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics TM ”, today announced that it has partnered with Clinilabs Drug Development Corporation (“...

CYBN:CC - Study Links Psilocybin Mushrooms to Decreased Risk of Opioid Addiction

The past couple of years have seen a rise in the popularity of alternative medicines. As people become more aware of the risks and side effects associated with the use of pharmaceuticals, interest in safer alternatives has increased exponentially. Psychedelics such as magic mushrooms hav...

CYBN:CC - Study Finds That Plant-Based Diets Lower Risk of Developing Type 2 Diabetes

A new study has found that consuming a healthy plant-based diet of legumes, nuts, vegetables, fruits and coffee is linked to a lower risk of developing type 2 diabetes. Healthy plant-based diets are rich in high-quality foods such as whole grains, vegetables and fruits. These diets have be...

CYBN:CC - Psychedelics Could Help Combat Alcoholism

Recently conducted studies have found that psychedelics may be useful in the treatment of various mental conditions , including anxiety, depression and alcoholism. “Psychedelic” is a term coined by Dr. Humphry Osmond in the 20th century. Osmond, who specialized in psychiatry...

CYBN:CC - InvestorNewsBreaks - Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO Featured in Latest Power Play Release

Cybin (NEO: CYBN) (NYSE American: CYBN ), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), was spotlighted in an episode of the Power Play by the Market Herald. Cybin CEO Doug Drysdale talked with host Dave Jackson about the company’s recent p...

CYBN:CC - The Power Play by The Market Herald Releases Interviews with Cybin and Baroyeca Gold & Silver

VANCOUVER, BC / ACCESSWIRE / April 13, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Cybin and Baroyeca Gold & Silver on their latest news. The Power Play by The Market Herald provides investors with a quick snapshot of what they need to kno...

CYBN:CC - Research Emphasizes Importance of Screening for Unhealthy Consumption of Alcohol

New research has found that during primary care visits , screening for unhealthy consumption of alcohol by patients through the use of a validated questionnaire is rarely done. This is despite the current recommendations provided by the U.S. Preventive Services Task Force. Figures show th...

Previous 10 Next 10